Locally Advanced Breast Cancer

Oncology·MeSH: Inflammatory Breast Neoplasms

Prevalence

287.0 / 100K

Incidence

128.0 / 100K/yr

6 drugs in development·1 company·7 clinical trials

Drug Pipeline by Phase

Phase 1/Phase 2(1)
DrugCompany
bnt323BioNTech SE (BNTX)

Compare drugs

BNT327 Dose Level 1 vs BNT327 Equivalent Q3W DoseBNT327 Dose Level 1 vs BNT327 Optimized DoseBNT327 Dose Level 1 vs Eribulin

Frequently asked questions

How many drugs are in development for Locally Advanced Breast Cancer?

BioSniper tracks 6 drugs in development for Locally Advanced Breast Cancer across 1 company.

How many clinical trials target Locally Advanced Breast Cancer?

There are 7 clinical trials targeting Locally Advanced Breast Cancer tracked by BioSniper.

What is the prevalence of Locally Advanced Breast Cancer?

The estimated prevalence of Locally Advanced Breast Cancer is approximately 287.0 per 100,000 population.

Deep-dive into Locally Advanced Breast Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Locally Advanced Breast Cancer — Drugs in Development & Clinical Trials | BioSniper